Tourmaline Bio, Inc. (TRML)
NASDAQ: TRML · Real-Time Price · USD
26.88
+0.62 (2.36%)
Nov 14, 2024, 4:00 PM EST - Market closed
Tourmaline Bio Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$65.00
Upside
+141.82%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $48 → $49 | Strong Buy | Maintains | $48 → $49 | +82.29% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +78.57% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +78.57% | May 14, 2024 |
| Truist Securities | Truist Securities | Strong Buy Reiterates $74 | Strong Buy | Reiterates | $74 | +175.30% | Mar 25, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $41 → $72 | Strong Buy | Maintains | $41 → $72 | +167.86% | Mar 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +78.57% | Mar 20, 2024 |
| Jefferies | Jefferies | Strong Buy Initiates $41 | Strong Buy | Initiates | $41 | +52.53% | Dec 15, 2023 |
| Truist Securities | Truist Securities | Strong Buy Initiates $43 | Strong Buy | Initiates | $43 | +59.97% | Nov 17, 2023 |
| Guggenheim | Guggenheim | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +86.01% | Oct 31, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $65 | Buy | Initiates | $65 | +141.82% | Oct 25, 2023 |